3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
49
Lung Neoplasms
25
Carcinoma, Hepatocellular
24
Small Cell Lung Carcinoma
16
Urinary Bladder Neoplasms
12
Cholangiocarcinoma
12
Breast Neoplasms
10
Biliary Tract Neoplasms
10
Neoplasms
9
Neoplasm Metastasis
9
Liver Neoplasms
9
Pancreatic Neoplasms
7
Carcinoma
6
Endometrial Neoplasms
5
Colorectal Neoplasms
5
Triple Negative Breast Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Neoplasms by Site
4
Gallbladder Neoplasms
4
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Respiratory Tract Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Renal Cell
3
Bile Duct Neoplasms
3
Adenocarcinoma
3
Thyroid Neoplasms
2
Thoracic Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Interventions
Specimen Handling
3
Nivolumab
3
Magnetic Resonance Spectroscopy
3
Biopsy
2
dehydroftorafur
1
X-Rays
1
Watchful Waiting
1
Taxes
1
Sigmoidoscopy
1
Radiotherapy, Intensity-Modulated
1
Proctoscopy
1
Phantoms, Imaging
1
Paclitaxel
1
Observation
1
Mitozytrex
1
Mitomycin
1
Ipilimumab
1
Fluorouracil
1
Fluorodeoxyglucose F18
1
Colonoscopy
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anal Canal Carcinoma
×
durvalumab
×
90 days
×
Clear all
No trials found.